UAMS Drug Trial Leads to First FDA-Approved Treatment for Blood Disorder Called Castleman’s Disease

LITTLE ROCK – The first-ever treatment for a rare blood disorder called multicentric Castleman’s disease was approved recently by the Food and Drug Administration after drug trials headed by a researcher at the University of Arkansas for Medical Sciences (UAMS).